Nystatin
Brand names: Nystan
A polyene antifungal used topically and orally (as a non-absorbed oral suspension) to treat and prevent candidal infections of the mouth, throat and gastrointestinal tract.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It binds ergosterol in the fungal cell membrane, forming pores that increase permeability and cause leakage of intracellular contents, giving fungicidal activity chiefly against Candida species.
Prescribing in practice
- It is essentially not absorbed from the gut, so it acts only on local mucosal or luminal Candida and is ineffective for systemic or deep candidal infection.
- For oral candidiasis the suspension should be retained in the mouth in contact with the affected areas before swallowing to maximise local effect.
- Continue treatment for the recommended period after lesions clear to reduce relapse, and consider treating predisposing factors such as poor denture hygiene.
Monitoring
Routine laboratory monitoring is not required; assess clinical response and consider further investigation if oral or gastrointestinal candidiasis fails to resolve.
Counselling the patient
- Hold the suspension in your mouth, swishing it around the affected areas, before swallowing.
- Keep using it for a few days after the soreness or white patches have gone.
- If you wear dentures, clean them well and leave them out overnight to help clear the infection.
Evidence & guidelines
Topical and oral nystatin is a long-established standard treatment for localised mucocutaneous candidiasis.
Reference: NICE CKS; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023